Afghanistan : COVID-19 Vaccine Support Project under the Asia Pacific Vaccine Access Facility
TBD
Project Details
-
Project Officer
ADB Disclosure
Central and West Asia Department
Request for information -
Country/Economy
Afghanistan -
Sector
- Health
Project Name | COVID-19 Vaccine Support Project under the Asia Pacific Vaccine Access Facility | ||||
Project Number | 55012-001 | ||||
Country / Economy | Afghanistan |
||||
Project Status | Active | ||||
Project Type / Modality of Assistance | Grant |
||||
Source of Funding / Amount |
|
||||
Operational Priorities | OP1: Addressing remaining poverty and reducing inequalities OP2: Accelerating progress in gender equality OP7: Fostering regional cooperation and integration |
||||
Sector / Subsector | Health / Disease control of communicable disease |
||||
Gender | Effective gender mainstreaming | ||||
Description | TBD | ||||
Project Rationale and Linkage to Country/Regional Strategy | TBD | ||||
Impact | Vulnerable groups are protected from COVID-19 (National Vaccination Deployment Plan The spread of severe acute respiratory syndrome coronavirus 2 is reduced, and confidence of citizens is restored (ADB's Support to Enhance COVID-19 Vaccine Access) |
Project Outcome | |
---|---|
Description of Outcome | Priority populations vaccinated against COVID-19 |
Progress Toward Outcome | |
Implementation Progress | |
Description of Project Outputs | COVID-19 vaccines procured and delivered to designated points Vaccine program implementation capacity strengthened |
Status of Implementation Progress (Outputs, Activities, and Issues) | |
Geographical Location | Nation-wide |
Safeguard Categories | |
---|---|
Environment | C |
Involuntary Resettlement | C |
Indigenous Peoples | C |
Summary of Environmental and Social Aspects | |
---|---|
Environmental Aspects | |
Involuntary Resettlement | |
Indigenous Peoples | |
Stakeholder Communication, Participation, and Consultation | |
During Project Design | |
During Project Implementation |
Responsible ADB Officer | ADB Disclosure |
Responsible ADB Department | Central and West Asia Department |
Responsible ADB Division | Afghanistan Resident Mission (AFRM) |
Timetable | |
---|---|
Concept Clearance | - |
Fact Finding | 10 Feb 2021 to 15 Mar 2021 |
MRM | 02 Mar 2021 |
Approval | 20 Apr 2021 |
Last Review Mission | - |
Last PDS Update | 21 Apr 2021 |
Grant 0786-AFG
Milestones | |||||
---|---|---|---|---|---|
Approval | Signing Date | Effectivity Date | Closing | ||
Original | Revised | Actual | |||
20 Apr 2021 | 09 May 2021 | 07 Jun 2021 | 30 Jun 2023 | - | - |
Financing Plan | Grant Utilization | ||||
---|---|---|---|---|---|
Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
Project Cost | 52.00 | Cumulative Contract Awards | |||
ADB | 50.00 | 30 Jun 2023 | 0.00 | 0.00 | 0% |
Counterpart | 2.00 | Cumulative Disbursements | |||
Cofinancing | 0.00 | 30 Jun 2023 | 0.00 | 0.00 | 0% |
Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.
The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.
The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.
In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.
-
Helping Protect Afghans against COVID-19
The Asian Development Bank’s $50 million grant to Afghanistan will help procure and deploy safe, high-quality COVID-19 vaccines, and strengthen the country’s capacity to implement its vaccine program.